Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: Implications for customized patient care

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 3156-3163

  Nooh, Mohammed M ^a,b   Nookala, Suba ^a,c,d   Kansal, Rita ^a,c   Kotb, Malak ^a,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR15 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 10; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ALLELE; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; PATIENT CARE; POLARIZATION; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS INFECTION;

CELL LINE, TRANSFORMED; CELL POLARITY; CYTOKINES; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HLA-DR7 ANTIGEN; HUMANS; RECEPTORS, ANTIGEN, T-CELL; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS;

EID: 79952764512     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002057     Document Type: Article

References (70)

1. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54: 535-551.
2. Kotb, M., A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M. T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, G. Thomson, et al. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8: 1398-1404.
3. Kotb, M., A. Norrby-Teglund, A. McGeer, K. Green, and D. E. Low. 2003. Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. Scand. J. Infect. Dis. 35: 665-669.
4. Frodsham, A. J., and A. V. Hill. 2004. Genetics of infectious diseases. Hum. Mol. Genet. 13(Spec. No. 2): R187-R194.
5. Kotb, M. 2004. Genetics of susceptibility to infectious diseases. ASM News 70: 457-463. (Pubitemid 41296065)
6. Kiryluk, K., J. Martino, and A. G. Gharavi. 2007. Genetic susceptibility, HIV infection, and the kidney. Clin. J. Am. Soc. Nephrol. 2(Suppl. 1): S25-S35.
7. Kotb, M. 2008. Diseases due to encapsulated bacteria. In Genetic Susceptibility to Infectious Diseases. R. A. Kaslow, J. M. McNicholl, and A. V. S. Hill, eds. Oxford University Press, New York, p. 351-371.
8. Kramnik, I. 2008. Genetic dissection of host resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr1 gene. Curr. Top. Microbiol. Immunol. 321: 123-148.
9. Blackwell, J. M., S. E. Jamieson, and D. Burgner. 2009. HLA and infectious diseases. Clin. Microbiol. Rev. 22: 370-385.
10. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5: 685-694.
11. Cunningham, M. W. 2003. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front. Biosci. 8: s533-s543.
12. Kotb, M. 1995. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin. Immunol. Immunopathol. 74: 10-22.
13. Shulman, S. T., G. Stollerman, B. Beall, J. B. Dale, and R. R. Tanz. 2006. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin. Infect. Dis. 42: 441-447.
14. Norrby-Teglund, A., and M. Kotb. 2000. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J. Med. Microbiol. 49: 849-852.
15. Chhatwal, G. S., and D. J. McMillan. 2005. Uncovering the mysteries of invasive streptococcal diseases. Trends Mol. Med. 11: 152-155.
16. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13: 470-511.
17. Low, D. E., B. Schwartz, and A. Mcgeer. 1998. The Reemergence of Severe Group A Streptococcal Disease: An Evolutionary Perspective. ASM Press, Washington, DC.
18. Aziz, R. K., and M. Kotb. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14: 1511-1517.
19. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68: 3523-3534.
20. Johnson, D. R., J. T. Wotton, A. Shet, and E. L. Kaplan. 2002. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J. Infect. Dis. 185: 1586-1595.
21. Basma, H., A. Norrby-Teglund, Y. Guedez, A. McGeer, D. E. Low, O. El- Ahmedy, B. Schwartz, and M. Kotb. 1999. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect. Immun. 67: 1871-1877.
22. Kansal, R. G., V. Datta, R. K. Aziz, N. F. Abdeltawab, S. Rowe, and M. Kotb. 2010. Dissection of the molecular basis for hypervirulence of an in vivo-selected phenotype of the widely disseminated M1T1 strain of group A Streptococcus bacteria. J. Infect. Dis. 201: 855-865.
23. Mitchell, T. J. 2003. The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat. Rev. Microbiol. 1: 219-230.
24. Nizet, V. 2007. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120: 13-22.
25. Kotb, M. 1995. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8: 411-426.
26. Norrby-Teglund, A., R. Lustig, and M. Kotb. 1997. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect. Immun. 65: 5209-5215.
27. Norrby-Teglund, A., S. Chatellier, D. E. Low, A. McGeer, K. Green, and M. Kotb. 2000. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 30: 3247-3255.
28. Norrby-Teglund, A., P. Thulin, B. S. Gan, M. Kotb, A. McGeer, J. Andersson, and D. E. Low. 2001. Evidence for superantigen involvement in severe group a streptococcal tissue infections. J. Infect. Dis. 184: 853-860.
29. Norrby, S. R., and A. Norrby-Teglund. 1997. Infections due to group A streptococcus: new concepts and potential treatment strategies. Ann. Acad. Med. Singapore 26: 691-693.
30. Norrby-Teglund, A., N. Ihendyane, and J. Darenberg. 2003. Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections. Scand. J. Infect. Dis. 35: 683-689.
31. Hill, A. V. 2006. Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet. 40: 469-486.
32. Hill, A. V. 1998. The immunogenetics of human infectious diseases. Annu. Rev. Immunol. 16: 593-617.
33. Hill, A. V. 1992. HLA and infection. J. R. Coll. Physicians Lond. 26: 11-16.
34. Clementi, M., and E. Di Gianantonio. 2006. Genetic susceptibility to infectious diseases. Reprod. Toxicol. 21: 345-349.
35. Carrington, M., and M. P. Martin. 2006. The impact of variation at the KIR gene cluster on human disease. Curr. Top. Microbiol. Immunol. 298: 225-257.
36. Feng, Z., and C. Castillo-Chavez. 2006. The influence of infectious diseases on population genetics. Math. Biosci. Eng. 3: 467-483.
37. Yang, N., and M. L. Hibberd. 2009. Genetics and Genomics of Infectious Diseases: advancing our understanding of host/pathogens and their interactions. Genome Med. 1: 52.
38. Alcaïs, A., L. Abel, and J. L. Casanova. 2009. Human genetics of infectious diseases: between proof of principle and paradigm. J. Clin. Invest. 119: 2506-2514.
39. Nooh, M. M., N. El-Gengehi, R. Kansal, C. S. David, and M. Kotb. 2007. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178: 3076-3083. (Pubitemid 46333188)
40. Nooh, M. M., R. K. Aziz, M. Kotb, A. Eroshkin, W. J. Chuang, T. Proft, and R. Kansal. 2006. Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J. Biol. Chem. 281: 35281-35288.
41. Aziz, R. K., R. A. Edwards, W. W. Taylor, D. E. Low, A. McGeer, and M. Kotb. 2005. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J. Bacteriol. 187: 3311-3318. (Pubitemid 40628684)
42. Tomai, M. A., P. M. Schlievert, and M. Kotb. 1992. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect. Immun. 60: 701-705.
43. Proft, T., and J. D. Fraser. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133: 299-306.
44. Petersson, K., G. Forsberg, and B. Walse. 2004. Interplay between superantigens and immunoreceptors. Scand. J. Immunol. 59: 345-355.
45. Proft, T., and J. D. Fraser. 2007. Streptococcal superantigens. Chem. Immunol. Allergy 93: 1-23.
46. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35. (Pubitemid 19033513)
47. al-Daccak, R., K. Mehindate, P. E. Poubelle, and W. Mourad. 1994. Signalling via MHC class II molecules selectively induces IL-1 beta over IL-1 receptor antagonist gene expression. Biochem. Biophys. Res. Commun. 201: 855-860.
48. Cole, B. C., A. D. Sawitzke, E. A. Ahmed, C. L. Atkin, and C. S. David. 1997. Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM. Infect. Immun. 65: 4190-4198.
49. Guo, W., W. Mourad, D. Charron, and R. Al-Daccak. 1999. Ligation of MHC class II molecules differentially upregulates TNF beta gene expression in B cell lines of different MHC class II haplotypes. Hum. Immunol. 60: 312-322.
50. Imanishi, K., H. Igarashi, and T. Uchiyama. 1992. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B. Infect. Immun. 60: 5025-5029.
51. Lavoie, P. M., J. Thibodeau, I. Cloutier, R. Busch, and R. P. Sékaly. 1997. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM. Proc. Natl. Acad. Sci. USA 94: 6892-6897.
52. Mehindate, K., R. al-Daccak, F. Damdoumi, and W. Mourad. 1996. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression. Eur. J. Immunol. 26: 2075-2080.
53. Mehindate, K., J. Thibodeau, M. Dohlsten, T. Kalland, R. P. Sékaly, and W. Mourad. 1995. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J. Exp. Med. 182: 1573-1577.
54. Norrby-Teglund, A., G. T. Nepom, and M. Kotb. 2002. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur. J. Immunol. 32: 2570-2577.
55. Scholl, P. R., A. Diez, R. Karr, R. P. Sekaly, J. Trowsdale, and R. S. Geha. 1990. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J. Immunol. 144: 226-230.
56. Suntharalingam, G., M. R. Perry, S. Ward, S. J. Brett, A. Castello-Cortes, M. D. Brunner, and N. Panoskaltsis. 2006. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355: 1018-1028.
57. Bone, R. C. 1996. A personal experience with SIRS and MODS. Crit. Care Med. 24: 1417-1418.
58. Calandra, T., and M. P. Glauser. 1990. Cytokines and septic shock. Diagn. Microbiol. Infect. Dis. 13: 377-381.
59. Dinarello, C. A. 1997. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112(6, Suppl.): 321S-329S.
60. Bjerre, A., B. Brusletto, E. A. Høiby, P. Kierulf, and P. Brandtzaeg. 2004. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit. Care Med. 32: 433-438.
61. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
62. Scumpia, P. O., and L. L. Moldawer. 2005. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit. Care Med. 33(12, Suppl.): S468-S471.
63. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915-924.
64. Gérard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547-550.
65. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205-1208.
66. Elenkov, I. J., D. G. Iezzoni, A. Daly, A. G. Harris, and G. P. Chrousos. 2005. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12: 255-269.
67. Steinhauser, M. L., C. M. Hogaboam, S. L. Kunkel, N.W. Lukacs, R. M. Strieter, and T. J. Standiford. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162: 392-399.
68. van der Poll, T., A. Marchant, C. V. Keogh, M. Goldman, and S. F. Lowry. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174: 994-1000.
69. Ashare, A., L. S. Powers, N. S. Butler, K. C. Doerschug, M. M. Monick, and G. W. Hunninghake. 2005. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L633-L640.
70. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64: 4733-4738.